- Clinical Effects of Zinc Supplementation in Patients Hospitalized with COVID-19: A Systematic Review and Meta-analysis
-
Park HW, Lee SY, An SH
- KMID: 2517311
- Korean J Clin Pharm.
- 2021 Jun;31(2):136-144.
- doi: 10.24304/kjcp.2021.31.2.136
Background: Zinc is known for modulating antiviral and antibacterial immunity and regulating inflammatory response. This study aimed to examine the effect of zinc supplementation on clinical outcomes of hospitalized COVID-19... -
- CITED
-
- Close
- SHARE
-
- Close
- A Survey on Willingness to Accept Community Pharmacist’s Consultation Service Regarding Well-dying
-
Shin KU, Sohn HS
- KMID: 2517312
- Korean J Clin Pharm.
- 2021 Jun;31(2):145-152.
- doi: 10.24304/kjcp.2021.31.2.145
Background: The Life-Sustaining Treatment Decision-Making Act has allowed anyone aged 19 or older to sign an Advance Directive not to receive life-sustaining treatment when they are in the ‘death process’.... -
- CITED
-
- Close
- SHARE
-
- Close
- Awareness on expiration date of repackaged prescription medications and pulverization of solid pills: A questionnaire study
-
Kim SY, Choi YJ, Sohn HS
- KMID: 2517307
- Korean J Clin Pharm.
- 2021 Jun;31(2):96-103.
- doi: 10.24304/kjcp.2021.31.2.96
Background: The number of elderly people with comorbidities who experience dysphagia associated with geriatric disorders, such as stroke, Parkinson’s disease, and Alzheimer’s dementia, is increasing. Consequently, the demand for long-term... -
- CITED
-
- Close
- SHARE
-
- Close
- Apixaban versus Warfarin in Patients with Chronic Kidney Disease; A Systematic Review and Meta-analysis
-
Nam JH, Kim CY, Lee YK, Jung DW, Gwak HY, Chung JE
- KMID: 2517306
- Korean J Clin Pharm.
- 2021 Jun;31(2):87-95.
- doi: 10.24304/kjcp.2021.31.2.87
Background: Patients with chronic kidney disease (CKD) are at a high risk of stroke-related morbidity, mortality, and bleeding. However, the overall risk/benefit of anticoagulant therapy among patients with CKD remains... -
- CITED
-
- Close
- SHARE
-
- Close
- Exploring the Perception on Drug Utilization Review System and DUR Modernization Pilot Project: A Qualitative Study Using Focus Group Interviews
-
Bea S, Jeon HL, Yoon D, Choi A, Lee H, Shin JY
- KMID: 2517308
- Korean J Clin Pharm.
- 2021 Jun;31(2):104-114.
- doi: 10.24304/kjcp.2021.31.2.104
Objective: To explore the perception of drug utilization review (DUR) system and DUR modernization pilot project among healthcare professionals and patients. Methods: We conducted 8 times of focus group interviews... -
- CITED
-
- Close
- SHARE
-
- Close
- Compatibility Study between Physiologically Based Pharmacokinetic (PBPK) and Compartmental PK Model Using Lumping Method: Application to the Voriconazole Case
-
Ryu Hj, Kang Wh, Chae Jw, Yun Hy
- KMID: 2517310
- Korean J Clin Pharm.
- 2021 Jun;31(2):125-135.
- doi: 10.24304/kjcp.2021.31.2.125
Background: Generally, pharmacokinetics (PK) models could be stratified into two models. The compartment PK model uses the concept of simple compartmentalization to describe complex bodies, and the physiologically based pharmacokinetic... -
- CITED
-
- Close
- SHARE
-
- Close
- Analysis of Medical Use and Treatment Costs of Hepatocellular Carcinoma Patients Using National Patient Sample Data
-
Oh BC, Cho JY, Kwon SH, Lee EK, Kim HL
- KMID: 2517313
- Korean J Clin Pharm.
- 2021 Jun;31(2):153-159.
- doi: 10.24304/kjcp.2021.31.2.153
Background: With increasing economic evaluation studies on the treatment of or screening tools for liver diseases that cause hepatocellular carcinoma (HCC), interest in the analysis of the medical utilization and... -
- CITED
-
- Close
- SHARE
-
- Close
- Pain-related Prescribing Patterns and Associated Factor in Breast Cancer Patients
-
Lee J, Park IB, Seo HJ
- KMID: 2517309
- Korean J Clin Pharm.
- 2021 Jun;31(2):115-124.
- doi: 10.24304/kjcp.2021.31.2.115
Background: With an increase in the number of breast cancer survivors, greater importance is attached to health-related quality of life, particularly pain and symptom control. This study aimed to identify... -
- CITED
-
- Close
- SHARE
-
- Close
